Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: January 23, 2009
Last updated: February 24, 2009
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Estimated Primary Completion Date: No date given